Page 380 - Read Online

Marasco et al. Hepatoma Res 2020;6:33 I http://dx.doi.org/10.20517/2394-5079.2020.01 Page 15 of 19

77. Lee JI, Lee HW, Kim SU, Ahn SH, Lee KS. Follow-up liver stiffness measurements after liver resection influence oncologic outcomes of
hepatitis-b-associated hepatocellular carcinoma with liver cirrhosis. Cancers (Basel) 2019;11:425.
78. Zhang J, Luo Y, Li C, Liu J, Xiang H, et al. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts
the prognosis of patients with hepatocellular carcinoma after liver resection. Biosci Trends 2019;13:351-7.
79. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, et al. A nssessment of liver function in patients with hepatocellular
carcinoma: a new evidence-based approach - the albi grade. J Clin Oncol 2015;33:550-8.
80. Lee YH, Koh YS, Hur YH, Cho CK, Kim HJ, et al. Effectiveness of the albumin-bilirubin score as a prognostic factor for early recurrence
after curative hepatic resection for hepatocellular carcinoma. Ann Hepato-Biliary-Pancreatic Surg 2018;22:335.
81. Amisaki M, Uchinaka E, Morimoto M, Tokuyasu N, Sakamoto T, et al. Post-operative albumin-bilirubin grade predicts long-term
outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int
2018;17:502-9.
82. Matsushima H, Takami Y, Ryu T, Yoshitomi M, Tateishi M, et al. Prognosis of hepatocellular carcinoma patients who achieved long-term
recurrence-free survival after curative therapy: impact of the ALBI grade. J Gastrointest Surg 2018;22:1230-8.
83. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, et al. Assessment of liver function in patients with hepatocellular
carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015;33:550-8.
84. Lin CY, Lin CC, Wang CC, Chen CL, Hu TH, et al. The ALBI grade is a good predictive model for very late recurrence in patients with
hepatocellular carcinoma undergoing primary resection. World J Surg 2020;44:247-57.
85. Lin CW, Chen YS, Lin CC, Lee PH, Lo GH, et al. Clinical and translational gastroenterology autophagy-related gene LC3 expression
in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection. Clin Transl
Gastroenterol 2018;9:166.
86. Song Q, Chen X, Hu W, Mei G, Yang X, et al. Downregulation of epstein-barr virus-induced gene 3 is associated with poor prognosis of
hepatocellular carcinoma after curative resection. Oncol Lett 2018;15:7751-9.
87. Fang Y, He J, Janssen HLA, Wu J, Dong L, et al. Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular
carcinoma recurrence. J Dig Dis 2018;19:155-69.
88. Hoki T, Katsuta E, Yan L, Takabe K, Ito F. Low DMT1 expression associates with increased oxidative phosphorylation and early
recurrence in hepatocellular carcinoma. J Surg Res 2019;234:343-52.
89. Chang YY, Yen CJ, Chan SH, Chou YW, Lee YP, et al. NEK2 promotes hepatoma metastasis and serves as biomarker for high recurrence
risk after hepatic resection. Ann Hepatol 2018;17:843-56.
90. Ji F, Zhang Z, Zhang Y, Shen SL, Cao QH, et al. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular
carcinoma after resection. BMC Cancer 2018;18:460.
91. Huang CF, Wang SC, Chang WT, Yeh ML, Huang CI, et al. Lower protein expression levels of MHC class I chain-related gene A in
hepatocellular carcinoma are at high risk of recurrence after surgical resection. Sci Rep 2018;8:15821.
92. Lv Y, Wei W, Huang Z, Chen Z, Fang Y, et al. Long non-coding RNA expression profile can predict early recurrence in hepatocellular
carcinoma after curative resection. Hepatol Res 2018;48:1140-8.
93. Wang Y, Tan PY, Handoko YA, Sekar K, Shi M, et al. NUF2 is a valuable prognostic biomarker to predict early recurrence of
hepatocellular carcinoma after surgical resection. Int J Cancer 2019;145:662-70.
94. Gao XH, Zhang SS, Chen H, Wang K, Xie W, et al. Lipoprotein (A): a promising prognostic biomarker in patients with hepatocellular
carcinoma after curative resection. Onco Targets Ther 2018;11:5917-24.
95. Xu Q, Yan Y, Gu S, Mao K, Zhang J, et al. A novel inflammation-based prognostic score: The fibrinogen/albumin ratio predicts prognoses
of patients after curative resection for hepatocellular carcinoma. J Immunol Res 2018;2018:4925498.
96. Oh TK, Choi YR, Cho JY, Yoon YS, Han HS, et al. The high-sensitivity C-reactive protein/albumin ratio predicts long-term oncologic
outcomes after curative resection for hepatocellular carcinoma. J Clin Med 2018;7:139.
97. Li C, Zhang XY, Peng W, Wen TF, Yan LN, et al. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the
outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection. Medicine (Baltimore) 2018;97:e11599.
98. Abbate V, Marcantoni M, Giuliante F, Vecchio FM, Gatto I, et al. HepPar1-positive circulating microparticles are increased in subjects
with hepatocellular carcinoma and predict early recurrence after liver resection. Int J Mol Sci 2017;18:1043.
99. Aryal B, Yamakuchi M, Shimizu T, Kadono J, Furoi A, et al. Predictive value of diminished serum PDGF-BB after curative resection of
hepatocellular cancer. J Oncol 2019;2019:1925315.
100. Liu H, Chen H, Wu X, Sun Y, Wang Y, et al. The serum proteomics tracking of hepatocellular carcinoma early recurrence following
radical resection. Cancer Manag Res 2019;11:2935-46.
101. Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, et al. Serum WFA+ -M2BP levels as a prognostic factor in patients with early
hepatocellular carcinoma undergoing curative resection. Liver Int 2016;36:293-301.
102. Kim HS, Kim SU, Kim BK, Park JY, Kim DY, et al. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level
predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection. Clin Mol Hepatol 2020;26:33-44.
103. Lee JH, Park JY, Kim DY, Ahn SH, Han KH, et al. Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with
sorafenib. Liver Int 2011;31:1144-9.
104. Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, et al. Value of transient elastography measured with fibroscan in predicting the
outcome of hepatic resection for hepatocellular carcinoma. Ann Surg 2012;256:706-13.
105. Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, et al.; Liver Cancer Study Group of Japan. Comparison of the outcomes between
an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese